TOUCHED BY LYME: Can you get disability benefits for Lyme disease?
Guest blogger Peter Burke, an attorney who focuses on disability law, summarizes some of the challenges faced by Lyme patients.
Author | LymeDisease.org
Guest blogger Peter Burke, an attorney who focuses on disability law, summarizes some of the challenges faced by Lyme patients.
How to protect yourself in tick territory.
Researchers at Brown University poke holes in the Klempner study, which the IDSA uses to justify denying long-term treatment to Lyme patients.
A new study by Allison DeLong, Barbara Blossom, Dr. Elizabeth Maloney, and Dr. Steven Phillips entitled “Antibiotic Retreatment of Lyme disease in Patients with Persistent Symptoms: A Biostatistical Review of Randomized, Placebo-controlled, Clinical Trials” examined the quality of the studies, statistical analysis and conclusions reached by the four NIH-funded clinical trials for persistent Lyme disease. For this blog, I am going to focus on one of them, the Klempner trial. It is the trial most commonly cited by the Infectious Diseases Society of America to support the IDSA guidelines recommendation that patients who remain ill after treatment should not be retreated. The trial involved both a seropositive arm (patients who tested positive for Lyme disease) and a seronegative arm (patients who tested negative for Lyme disease).
Guest blogger Jennifer Crystal revisits the spot where a tick gave her Lyme disease 15 years ago.
A prominent Lyme-treating physician from New York calls for an all-out effort to combat the Lyme epidemic.
Log in to chat with investigative reporter Mary Beth Pfeiffer, who wrote a series on Lyme in the Poughkeepsie Journal
Lyme activist Trish McCleary tells how and why she founded “S-L-A-M.”
A new feature on the Centers for Disease Control’s website takes a narrow view of Lyme diagnosis.
Guest columnist Toni Bernhard’s recent blog about what not to say to sick people brought a huge response from readers. Here’s more on the subject.
End of content
End of content